These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8336397)

  • 41. [Study on cases of D dimer values were dissociated from FDP-E].
    Himizu M; Ishii K; Katagiri H; Saga K; Ono F; Yamamoto M; Todoroki T; Kawai Y; Watanabe K; Iri H
    Rinsho Byori; 1991 Mar; 39(3):302-8. PubMed ID: 2051606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
    Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
    Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prototype quantitative assay for fibrinogen/fibrin degradation products. Clinical evaluation.
    Sigal SH; Cembrowski GS; Shattil SJ; Brown NM; Schifreen RS; Schwartz MW
    Arch Intern Med; 1987 Oct; 147(10):1790-3. PubMed ID: 3662708
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
    Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T; Kobayashi H; Kario K; Suzuki S
    Semin Thromb Hemost; 2000; 26(1):101-7. PubMed ID: 10805290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The roles of renal catabolism and uremia in modifying the clearance of fibrinogen and its degradative fragments D and E.
    Iio A; Rutherford WE; Wochner RD; Spilberg I; Sherman LA
    J Lab Clin Med; 1976 Jun; 87(6):934-46. PubMed ID: 932524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conventional detection method of fibrinogen and fibrin degradation products using latex piezoelectric immunoassay.
    Aizawa H; Kurosawa S; Tozuka M; Park JW; Kobayashi K; Tanaka H
    Biosens Bioelectron; 2003 May; 18(5-6):765-71. PubMed ID: 12706590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Intraglomerular coagulation in patients with glomerulonephritis, with special reference to FDP D-dimer].
    Shibata T; Ura S; Hirai Y; Taura K; Harada T; Hara K
    Nihon Naika Gakkai Zasshi; 1983 Sep; 72(9):1143-9. PubMed ID: 6663183
    [No Abstract]   [Full Text] [Related]  

  • 52. [Fibrin degradation products in the urine in diabetic nephropathy].
    Khristov V; Apostolov P; Stamenova T
    Vutr Boles; 1979; 18(4):32-6. PubMed ID: 494630
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [False positive FDP test associated with malignant lymphoma].
    Kitazume K; Usuki K; Endo M; Osawa M; Iki S; Urabe A
    Rinsho Ketsueki; 1997 Jan; 38(1):52-7. PubMed ID: 9028162
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.
    Takahagi S; Mihara S; Iwamoto K; Morioke S; Okabe T; Kameyoshi Y; Hide M
    Allergy; 2010 May; 65(5):649-56. PubMed ID: 19845571
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibrin deposits in the glomeruli and fibrin/fibrinogen degradation products (FDP) in the blood and urine in some renal diseases.
    Tishkov I; Tschoukanov C; Doytshinov D; Shipkova P
    Int Urol Nephrol; 1982; 14(1):89-93. PubMed ID: 7118491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on the fragments of FDP in 3 non-DIC patients with increased FDP levels in the sera].
    Okumura N; Furuwatari C; Ishikawa S; Furihata K; Katsuyama T; Kanai M; Shinoda T; Nakahata T; Saitoh H
    Rinsho Byori; 1993 Feb; 41(2):220-6. PubMed ID: 8361025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid quantitative evaluation of plasma D-dimer levels in thrombotic states using an automated latex photometric immunoassay.
    Kario K; Matsuo T; Kabayashi H; Matsuo M; Yamamoto K; Sakurai G; Baba M
    Thromb Res; 1992 May; 66(2-3):179-89. PubMed ID: 1412191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical observations on renal vein blood fibrin degradation products (FDP) in glomerulonephritis (author's transl)].
    Tomura S
    Nihon Jinzo Gakkai Shi; 1979 May; 21(3):233-44. PubMed ID: 470233
    [No Abstract]   [Full Text] [Related]  

  • 59. Determination of FDP in human plasma by a novel latex immunoassay.
    Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K
    Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Fibrin and fibrinogen degradation products (FDP) in renal diseases. II. Serum and urinary FDP in different morphological forms of glomerulonephritis].
    Ratajczak T; Rabczyński J; Szewczyk Z
    Pol Arch Med Wewn; 1978 Apr; 59(4):429-40. PubMed ID: 662758
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.